Personalized medicine major Myriad Genetics, Inc.’s MYGN wholly-owned subsidiary Myriad RBM, Inc. recently announced the release of landmark research work from the Milieu Interieur Project by Institut ...
TruCulture whole blood collection and stimulation system has revolutionized immune monitoring, especially for pharmacodynamic Phase 1 clinical trials. TruCulture tubes are pre-loaded with proprietary ...
PARIS, France and SALT LAKE CITY, Utah, March 20, 2014 – Institut Pasteur and Myriad RBM, a wholly-owned subsidiary of Myriad Genetics, Inc., today announced they have published an initial data ...
Myriad RBM, a wholly-owned subsidiary of Myriad Genetics, said today it will join the Institut Pasteur to launch a research collaboration aimed at fighting the worldwide epidemic of tuberculosis. The ...
The TruCulture system will be utilized for blood collection and culture. Rules-Based Medicine has signed on as a collaborator on the Institut Pasteur research project called Milieu Interieur (or the ...
Myriad Genetics ($MYGN) is teaming up with the Institut Pasteur for a research project to address the growing tuberculosis (TB) epidemic, continuing the company's ...
Personalized medicine major Myriad Genetics, Inc.’s MYGN wholly-owned subsidiary Myriad RBM, Inc. recently announced the release of landmark research work from the Milieu Interieur Project by Institut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results